Krishnan Suma

President, R&D, Director, 10% OwnerKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.6M
Net Open-Market Flow
-$6.6M
Transactions
10
10 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)407$257.32$105K1.4M
Mar 4, 2026Sell(S)589$258.54$152K1.4M
Mar 4, 2026Sell(S)668$259.61$173K1.4M
Mar 4, 2026Sell(S)4K$260.37$955K1.4M
Mar 4, 2026Sell(S)2K$266.42$453K1.4M
Mar 4, 2026Sell(S)2K$262.35$508K1.4M
Mar 4, 2026Sell(S)2K$263.58$593K1.4M
Mar 4, 2026Sell(S)5K$264.64$1.3M1.4M
Mar 4, 2026Sell(S)6K$265.16$1.6M1.4M
Mar 4, 2026Sell(S)3K$261.41$766K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001298711-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: